BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhai XR, Tong JJ, Wang HM, Xu X, Mu XY, Chen J, Liu ZF, Wang Y, Su HB, Hu JH. Infection deteriorating hepatitis B virus related acute-on-chronic liver failure: a retrospective cohort study. BMC Gastroenterol 2020;20:320. [PMID: 32993547 DOI: 10.1186/s12876-020-01473-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Z, Yang Z, Cheng Q, Hu X, Liu M, Liu Y, Liu T, Ma K, Zhang M, Luo X, Chen T, Ning Q. Establishment and validation of a prognostic model for hepatitis B virus‑related acute-on-chronic liver failure patients with bacterial infection. Hepatol Int 2021. [PMID: 34855105 DOI: 10.1007/s12072-021-10268-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Khanam A, Kottilil S. Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and Management. Front Med (Lausanne) 2021;8:752875. [PMID: 34820395 DOI: 10.3389/fmed.2021.752875] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Siregar AS, Nyiramana MM, Kim EJ, Cho SB, Woo MS, Lee DK, Hong SG, Han J, Kang SS, Kim DR, Choi YJ, Kang D. Oyster-Derived Tyr-Ala (YA) Peptide Prevents Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure by Suppressing Inflammatory, Apoptotic, Ferroptotic, and Pyroptotic Signals. Mar Drugs 2021;19:614. [PMID: 34822485 DOI: 10.3390/md19110614] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Zhang M, Xu X, Liu W, Zhang Z, Cheng Q, Yang Z, Liu T, Liu Y, Ning Q, Chen T, Qi J. Proton Pump Inhibitor Therapy Increases the Risk of Spontaneous Bacterial Peritonitis in Patients with HBV-Related Acute-on-Chronic Liver Failure. Adv Ther 2021;38:4675-94. [PMID: 34308513 DOI: 10.1007/s12325-021-01844-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]